Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 464802011 | Co-beneldopa 12.5mg/50mg dispersible tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1190004016 | Co-beneldopa 12.5mg/50mg dispersible tablet (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3228621000052112 | benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Is a | Co-beneldopa product | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Is a | Product containing benserazide and levodopa (medicinal product) | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has active ingredient | Benserazide (substance) | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has active ingredient | Levodopa (substance) | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Is a | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has manufactured dose form | dispergerbar tablett | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Has manufactured dose form | Tablet for oral suspension | false | Inferred relationship | Some | ||
| benserazid 12,5 mg + levodopa 50 mg, dispergerbar tablett | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR